Intracellular Pathogens and Innate Immunity
细胞内病原体和先天免疫
基本信息
- 批准号:7177234
- 负责人:
- 金额:$ 5.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-30 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Macrophages play pivotal roles in the biology of infectious diseases as hosts to intracellular pathogens, mediators of inflammation, and orchestrators of acquired immunity. It is no surprise that among most of the NIAID priority pathogens, macrophages are critical to the outcome of infection. A central hypothesis of this Program Project is that intracellular pathogens manipulate the response of macrophages to promote disease. Furthermore, the transcriptional response of macrophages to infection serves as a fundamental read-out of the overall response.
The purpose of this Program Project is to use a taxonomically and structurally distinct and clinically relevant panel of intracellular pathogens to establish the transcription profile of macrophages in response to microbial infection using a newly developed and novel microarray containing probes for all known mouse genes (Core B). This transcriptional profile will then serve as a benchmark to understand how the host response is manipulated by each pathogen. By profiling the transcriptional response of macrophages to microbial mutants that are defective in their pathogenic interactions with macrophages, we will learn how pathogens manipulate host cells to promote infection. By using macrophages derived from knockout mice in combination with microbial mutants, we will identify the pathways of innate immune recognition that determine the host response and how pathogens can manipulate these pathways for their benefit. These studies will illuminate essential and conserved pathways of macrophage control of innate immunity, thereby providing potential targets of therapeutic intervention as well as pathogenic signatures that will serve to uncover basic mechanisms of microbial pathogenesis and host response. The specific Aims are to (1) Identify microbial determinants of pathogenesis that affect macrophage innate immune responses in Listeria monocytogenes, Francisella tularensis, Mycobacterium tuberculosis and Histoplasma capsulatum; (2) Characterize the intracellular replication and trafficking of microbial mutants in bone marrow-derived macrophages. (3) Characterize host gene expression profiles using custom synthesized DNA microarrays in response to wild-type and mutant microbial pathogens in macrophages from wild-type and mutant mice.
巨噬细胞在传染病的生物学中起关键作用,作为细胞内病原体的宿主,炎症的介体以及获得免疫的序曲。毫不奇怪的是,在大多数NIAID优先病原体中,巨噬细胞对感染的结果至关重要。该计划项目的一个核心假设是,细胞内病原体操纵巨噬细胞对促进疾病的反应。此外,巨噬细胞对感染的转录反应是整体反应的基本读数。
该计划项目的目的是使用细胞内病原体的分类学和结构上不同和临床相关的面板,以使用新发达的和新的微阵列含有所有已知小鼠基因的探针(Core B)来建立巨噬细胞的转录谱,以应对微生物感染。然后,此转录曲线将作为基准,以了解每种病原体如何操纵宿主反应。通过分析巨噬细胞对微生物突变体的转录反应,这些突变体在其与巨噬细胞的致病相互作用中有缺陷,我们将学习病原体如何操纵宿主细胞以促进感染。通过将源自基因敲除小鼠与微生物突变体结合使用的巨噬细胞,我们将确定确定宿主反应的先天免疫识别途径,以及病原体如何为它们的益处操纵这些途径。这些研究将阐明对先天免疫的巨噬细胞控制的必要和保守途径,从而提供治疗干预的潜在靶标,以及致病性特征,这些靶标将有助于发现微生物发病机理和宿主反应的基本机制。具体目的是(1)确定影响巨噬细胞单核细胞增生液,francisella tularensis,tobleculculculosis和Histoplasma capsulatum中巨噬细胞免疫反应的发病机理的微生物决定因素; (2)表征微生物突变体在骨髓来源的巨噬细胞中的细胞内复制和运输。 (3)使用自定义合成的DNA微阵列表征宿主基因表达谱,以响应野生型和突变小鼠的巨噬细胞中的野生型和突变微生物病原体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL A PORTNOY其他文献
DANIEL A PORTNOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL A PORTNOY', 18)}}的其他基金
The role of Listeria cyclic-di-AMP during infection and immunity
李斯特菌环二腺苷在感染和免疫过程中的作用
- 批准号:
8234225 - 财政年份:2011
- 资助金额:
$ 5.76万 - 项目类别:
Listeria-based vaccines engineered to modulate the innate immune system
基于李斯特菌的疫苗旨在调节先天免疫系统
- 批准号:
8296801 - 财政年份:2011
- 资助金额:
$ 5.76万 - 项目类别:
Project 1: Listeria metabolites and innate immunity
项目1:李斯特菌代谢物与先天免疫
- 批准号:
10190578 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
The intersection of innate and adaptive immunity to intracellular pathogens
针对细胞内病原体的先天免疫和适应性免疫的交叉点
- 批准号:
10655288 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
Project 1: Innate immune responses triggered by Listeria monocytogenes
项目1:单增李斯特菌引发的先天免疫反应
- 批准号:
9977105 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
The intersection of innate and adaptive immunity to intracellular pathogens
针对细胞内病原体的先天免疫和适应性免疫的交叉点
- 批准号:
10400179 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
相似国自然基金
CD40hiCD138hiPIR-Ahi巨噬细胞训练免疫的形成及其促进慢性排斥反应的机制研究
- 批准号:82371794
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脑边界相关巨噬细胞介导肠道菌群失调致POCD的免疫代谢机制研究
- 批准号:82371208
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
GPC3-CD81通过SHP-2调控肿瘤相关巨噬细胞极化介导非小细胞肺癌免疫放疗抵抗的分子机制研究
- 批准号:82373217
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向巨噬细胞TMEM175蛋白的肿瘤免疫治疗潜力及机制研究
- 批准号:82303752
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PD-L1+肿瘤相关巨噬细胞促进IL-1R1+Treg细胞亚群重编程参与胃癌免疫逃逸的作用和机制研究
- 批准号:82303966
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 5.76万 - 项目类别:
Investigating the role of intestinal microbiota in intestinal macrophage immune memory
研究肠道微生物群在肠道巨噬细胞免疫记忆中的作用
- 批准号:
491179 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
Fellowship Programs
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
- 批准号:
10638364 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
Role of STING in Cholestatic Liver Injury
STING 在胆汁淤积性肝损伤中的作用
- 批准号:
10637131 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
THE IMMUNE SELF-ASSOCIATED STORAGE ORGANELLE (SASO)
免疫自联存储细胞器 (SASO)
- 批准号:
10639168 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别: